CNS Pharmaceuticals, Inc. — Form C-TR (Regulation Crowdfunding)
CNS Pharmaceuticals, Inc. of HOUSTON, TX filed a Form C-TR (Regulation Crowdfunding) with the SEC on 2020-04-24.
Offering
- Filed: 2020-04-24
- Form: C-TR
- Accession: 0001683168-20-001280
Issuer
- CIK: 0001729427
- Website: www.cnspharma.com
- Legal status: Corporation
- Organized in: NV
- Incorporated: 2017-07-27
- Address: 2100 WEST LOOP SOUTH, HOUSTON, TX, 77027
People (11)
| Name | Role | Location |
|---|
| Matthew Lourie | Chief Financial Officer | The Woodlands, TX |
| Christopher Downs | Chief Financial Officer | Las Vegas, NV |
| Donald H. Picker | Director | HOUSTON, TX |
| Jerzy (George) Gumulka | Director | HOUSTON, TX |
| John Climaco | Chief Executive Officer | HOUSTON, TX |
| John Climaco | Chief Executive Officer and Director | HOUSTON, TX |
| John Climaco | President, Chief Executive Officer and Director | HOUSTON, TX |
| Andrzej Andraczke | Director | HOUSTON, TX |
| Andrzej Andraczke | Directror | HOUSTON, TX |
| Jeffry Keyes | Director | Houston, TX |
| Carl Evans | Director | HOUSTON, TX |
Reg CF filing history (4)
More